Philip Morris snaps six straight sessions of gains
Shares of Philip Morris (NYSE:PM) snapped six straight sessions of gains, as the stock closed 0.74% down at $122.89 on ...
Let Freedom Zyn
Let freedom ryng: On Thursday, the Food and Drug Administration (FDA) authorized the marketing of 20 Zyn nicotine pouch ...
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Buy Rating for Philip Morris: Strategic Positioning and FDA Approval of ZYN Pouches
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...